Literature DB >> 2101327

Kinetics of pleural exudation and cellular alterations induced by antigen in actively sensitized rats.

M C Lima1, M A Martins, S A Perez, J M Peixoto, P M Silva, R S Cordeiro.   

Abstract

This study was undertaken to characterize the different phases of the allergic pleurisy induced by ovalbumin in actively sensitized rats. The reaction was triggered by the intrathoracic injection of ovalbumin (12 micrograms/cavity) into animals sensitized 14 days before. The challenge caused, at 30 min, a drastic mast cell degranulation and exudation which peaked within 4 h. At this time, an intense pleural leucocyte recruitment also occurred, accounted for by an increase in the mononuclear cell counts and by a predominant influx of neutrophils. After 24 h, the mast cell counts started to recover, accompanied by a long-lasting (96 h) accumulation of pleural eosinophils. Forty-eight hours later, the exudation and neutrophils were at basal levels, whereas mast cell counts increased progressively to reach control values at 120 h. This study describes the time course of the exudative and cellular alterations observed during pleural inflammation induced by low antigen concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2101327

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  2 in total

1.  Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.

Authors:  P M Silva; A C Alves; M F Serra; A L Pires; J P Silva; E O Barreto; R S Cordeiro; P J Jose; M M Teixeira; V Lagente; M A Martins
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Nedocromil sodium prevents in vivo generation of the eosinophilotactic substance induced by PAF but fails to antagonize its effects.

Authors:  P M e Silva; M A Martins; H C Castro-Faria-Neto; P T Bozza; A L Pires; R S Cordeiro; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.